• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

MGMA Express Concerns Over “All or Nothing” Approach to Meaningful Use

by Jasmine Pennic 08/22/2013 7 Comments

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

MGMA express concerns that the current “all or nothing” approach to achieving meaningful use may prove to be problematic for providers to meet Stage 2 requirements.

The Medical Group Management Association (MGMA), which represents 22,500 members who lead 13,200 organizations nationwide recently requested the HHS should “immediately institute an indefinite moratorium on penalties for physicians that successfully completed Stage 1 meaningful use requirements.”

In the letter sent on August 21st to HHS Secretary Kathleen Sebelius, Susan Turney MD, MS, President & CEO of MGMA said,

Susan Turney, MD, MS, President and CEO, MGMA president and CEO.
Susan Turney, MD, MS, President and CEO, MGMA

”MGMA has been very supportive of the federal efforts to promote and encourage the implementation and adoption of EHRs as a pathway toward improved clinical performance and enhanced administrative efficiency. We also were strongly supportive of the decision to extend the start date of Stage 2 by one year. However, it has become clear that the alignment between the more rigorous Stage 2 requirements and the ability of the vendor community to produce and deploy Stage 2 certified products has simply not occurred at the pace anticipated.”

Another MGMA key concern is vendor readiness with currently more than 2,200 products and almost 1,400 “complete” EHRs certified for meaningful use stage 1 and only 75 products and 21 complete EHRs certified for meaningful use stage 2.

“This lack of vendor readiness has significant implications for EPs. Without the appropriate software upgrades and timely vendor support, EPs will be unable to meet the Stage 2 requirements and thus will be unfairly penalized starting in 2015,” said Turney.

Other vendor readiness concerns mentioned were postponed software upgrades, lengthy implementation/training timelines, ICD-10 and “all or nothing” approach to achieving meaningful use stage 2 stringent requirements.

In her letter, Stream urged HHS to immediately take the additional following steps:

  • Extend the reporting period for Stage 2 incentives
  • Extend the reporting period for Stage 1 incentives
  • Conduct a comprehensive vendor survey
  • Build additional flexibility into the Stage 2 reporting requirements

“We believe adoption of these recommendations will help ensure that the Administration’s goal of having a significant majority of our nation’s EPs adopt interoperable EHRs is kept on track and that additional fairness and flexibility is  appropriately built in to this important incentive program,”said Turney.

Read the letter to HHS here

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

Digital Health Funding Q3 2025: Choppy Undercurrents Beneath a Steady Surface

Featured Interview

ConcertAI VP Shares View on AI Hallucinations and the Fabricated Data Crisis in Scientific Publishing

Most-Read

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

KLAS Report: Epic's Native Ambient Speech Tool Reshapes Customer AI Strategies

KLAS Report: Epic’s Native Ambient Speech Tool Reshapes Customer AI Strategies

Epic Unveils MyChart Central and New APIs to Advance Interoperability at Open@Epic

Epic Outlines Roadmap for Next-Generation Data Sharing at Open@Epic

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

Oracle Confirms Layoffs in Kansas City

Oracle Confirms Layoffs in Kansas City

Philips Future Health Index 2025: AI and Digital Tech Can Help Solve Cardiac Care Crisis

Philips Future Health Index 2025: AI and Digital Tech Can Help Solve Cardiac Care Crisis

Optain Health Secures $26M to Advance AI-Powered Retinal Screening

Optain Health Secures $26M for AI-Powered Retinal Screening

Sutter Health and Epic Launch "Sutter Sync" to Optimize Remote Chronic Care

Sutter Health and Epic Launch “Sutter Sync” to Optimize Remote Chronic Care

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |